Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorhexidine gluconate + metronidazole is an investigational topical combination antimicrobial gel consisting of 0.5% chlorhexidine gluconate and 1.5% metronidazole. It is being studied by H.P. Government Dental College and Hospital Shimla as an adjunct to scaling and root planing (SRP) for the management of plaque-induced gingivitis. Chlorhexidine gluconate acts as a broad-spectrum antiseptic that disrupts microbial cell membranes, while metronidazole is a nitroimidazole antibiotic that targets anaerobic bacteria by inhibiting nucleic acid synthesis. The combination is designed to target the oral bacterial biofilm responsible for gingival inflammation, with clinical evidence suggesting it is more effective than chlorhexidine alone in reducing gingival index and sulcus bleeding scores.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorhexidine gluconate + metronidazole.